Heidelberg, Germany

Ulrich Graedler

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 33(Granted Patents)


Location History:

  • Heidelberg, DE (2011 - 2013)
  • Weinheim, DE (2013 - 2018)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Ulrich Graedler: Innovator in Pharmaceutical Compounds

Introduction

Ulrich Graedler is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds with therapeutic applications. With a total of 8 patents to his name, Graedler's work has had a notable impact on medical science.

Latest Patents

Graedler's latest patents include groundbreaking inventions such as imidazolonylquinoline compounds and their therapeutic uses. His work on atropisomers, solid forms, salt forms, and deuterated derivatives of the ATM inhibitor 8-(1,3-Dimethyl-1H-pyrazol-4-yl)-1-(3-fluoro-5-methoxypyridin-4-yl)-7-methoxy-3-methyl-1,3-dihydroimidazo[4,5-c]quinolin-2-one showcases his innovative approach to drug development. Additionally, he has developed compounds for the inhibition of cyclophilins, which are useful in treating cyclophilin-related disorders.

Career Highlights

Throughout his career, Graedler has worked with notable companies such as Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research.

Collaborations

Graedler has collaborated with esteemed colleagues, including Margarita Wucherer-Plietker and Christina Esdar. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Ulrich Graedler's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of therapeutic compounds that address critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…